Sign in
Administration of interferon for two or more years decreases early stage hepatocellular carcinoma recurrence rate after radical ablation: A retrospective study of hepatitis C virus-related liver cancer
Journal article   Peer reviewed

Administration of interferon for two or more years decreases early stage hepatocellular carcinoma recurrence rate after radical ablation: A retrospective study of hepatitis C virus-related liver cancer

Kenji Ikeda, Masahiro Kobayashi, Yuya Seko, Norihiro Imai, Miharu Hirakawa, Yusuke Kawamura, Hitomi Sezaki, Tetsuya Hosaka, Norio Akuta, Satoshi Saitoh, …
Hepatology research, Vol.40(12), pp.1168-1175
Received 13 April 2010; revision 11 July 2010; accepted 14 July 2010.
12/2010
PMID: 20849431

Abstract

hepatitis C hepatocellular carcinoma Interferon prevention recurrence

Metrics

1 Record Views

Details